Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0001918845-26-000008

Chief Medical Officer sold 3,970 shares at $18.01 ($71,508)

  • Chief Medical Officer acquired 3,970 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Doyle Mittie · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-04-06 Exercise or conversion : show line 1 in the form 10b5-1 +3,970 $12.65 $50,221 7,592 D
2026-04-06 Sale : show line 2 in the form 10b5-1 −3,970 $18.01 $71,508 3,622 D
Open-market sales · 3,970 sh · avg $18.01 · $71,508

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-04-06 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −3,970 210,530 D
Loading xslF345X06/form4-04082026_080437.xml…